Commentary & Opinion
New Data on Cancer Rates Among HIV-Positive People "Underline" Need for Antiretrovirals That Restore Immune Function, Opinion Piece Says
December 4, 2007
New data on cancer rates among HIV-positive people "underline" the need for the development of antiretroviral drugs that "restore immune function more effectively" than currently available treatments, Mark Wainberg -- director of McGill University's AIDS Centre at the Jewish General Hospital in Montreal, Canada, and former president of the International AIDS Society -- writes in a Washington Post opinion piece.
According to Wainberg, although the number of cancers seen among HIV-positive people could "plateau," widespread "damage" to the immune system already might have occurred in almost all patients, regardless of when they were diagnosed, by the time they start antiretroviral therapy. The "changes" the data on cancer "reflect in the evolution of HIV/AIDS as a long-term condition and in the quality of life of those living with it are vivid reminders that AIDS remains a fearsome disease, despite all the progress we've achieved over a quarter-century in therapies, acceptance and awareness," Wainberg concludes (Wainberg, Washington Post, 12/4).
District Should "Remain Vigilant" as Senate Votes on Bill That Would Remove Ban on Funding for Needle-Exchange Programs, Letter Says
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.